相关实验视频
Updated: May 25, 2025

07:34
Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
9.6K
集成蛋白β2在通过血造干细胞移植的治疗性血管生成中起着重要作用
Orie Saino1, Yuko Ogawa1, Kazuta Yasui2
1Department of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, 2-2, Minatojima-Minamimachi, Chou-Ku, Kobe 650-0047, Hyogo, Japan.
Life (Basel, Switzerland)
|February 26, 2025
概括
血造干细胞 (HSC) 治疗脑梗塞有希望,但存在不响应者. 这项研究确定了HSC上的整合素β2 (CD18) 表达作为治疗成功的关键预测因子,有助于识别非响应者.
科学领域:
- 再生医学是一种再生医学.
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 造血干细胞 (HSC) 疗法证明了对脑梗塞的疗效.
- 患者对HSC疗法的不响应限制了其临床应用.
- 了解不响应是建立HSC治疗作为标准治疗的关键.
研究的目的:
- 识别与治疗机制相关的移植细胞特征.
- 为了预测脑梗塞的HSC治疗中的治疗成功.
- 为了确定识别不响应患者的标志物.
主要方法:
- 研究了细胞粘附和间隙结在HSC治疗中的作用.
- 使用了脑梗塞的小鼠模型.
- 在CD34阳性 (CD34+) 细胞上量化了整合素β2 (CD18) 的表达.
主要成果:
- HSC疗法通过间隙连接激活受伤的大脑内皮细胞,这取决于细胞粘附.
- 在CD34+细胞上的整体蛋白β2 (CD18) 表达对于脑梗塞治疗效果至关重要.
- 较低的CD18表达与治疗效率的降低相关,无论细胞数量如何.
结论:
- 在CD34+细胞上的CD18表达是移植的HSC的重要标记物.
- CD18定量可以识别脑梗塞的HSC治疗不响应者.
- 这种标志物对于评估由细胞粘附介导的基于细胞的疗法至关重要.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
Activation of Integrins
3.2K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K

